Alpha-Thalassemia: Clinical Trials

5 trials for Alpha-Thalassemia, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 active not recruiting, 1 completed, 1 enrolling by invitation, 1 recruiting. 5 Not applicable.

By phase and status

PhaseTrialsStatus
Not applicable5Active not recruiting 1, Completed 1, Enrolling by invitation 1, Recruiting 1, Unknown 1

Follow Alpha-Thalassemia: new trials by email Literature Review of Alpha-Thalassemia trials Research Report on Alpha-Thalassemia

Trials (filtered) newest first · largest first

All 5 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Uncovering the Etiologies of Non-immune Hydrops Fetalis
Whole genome sequencing - Non-Immune Hydrops Fetalis
Not applicableEnrolling by invitationUniversity of California, San Francisco5002022-03-012026-04-17
In-utero Hematopoietic Stem Cell Transplantation for the Treatment of Fetuses With Bart's Hydrops Fetalis Syndrome
in-utero HSCT - Haemoglobin Barts Hydrops
Not applicableRecruitingChinese University of Hong Kong102021-10-012023-04-12
Multicentric Prospective Study to Screen Inborn Errors of Metabolism in Non-immune Hydrops (NIH) Fetalis by Massively Parallel Sequencing
NON-IMMUNE HYDROPS FETALIS diagnosis - Non-Immune Hydrops Fetalis
Not applicableCompletedHospices Civils de Lyon712021-04-122024-11-08
Hydrops: Diagnosing & Redefining Outcomes With Precision Study
Exome sequencing - Hydrops Fetalis, Birth Defect
Not applicableActive not recruitingUniversity of California, San Francisco5002018-10-112026-04-17
Precision Medical Research of Non-immune Fetal Hydrops (NIFH)-From Prenatal Diagnosis to Intrauterine Treatment
intrauterine intervention - Fetal Hydrops
Not applicableUnknownShanghai First Maternity and Infant Hospital1442016-12-012016-12-12

Narrower conditions

Hydrops Fetalis (5)  ·  Congenital Abnormalities (1)

Broader conditions

Congenital, Hereditary, and Neonatal Diseases and Abnormalities (5)  ·  Edema (5)  ·  Erythroblastosis, Fetal (5)  ·  Female Urogenital Diseases and Pregnancy Complications (5)  ·  Fetal Diseases (5)  ·  Genetic Diseases, Inborn (5)  ·  Hematologic Diseases (5)  ·  Hemic and Lymphatic Diseases (5)  ·  Hemoglobinopathies (5)  ·  Immune System Diseases (5)  ·  Pathological Conditions, Signs and Symptoms (5)  ·  Pregnancy Complications (5)  ·  Signs and Symptoms (5)  ·  Thalassemia (5)  ·  Urogenital Diseases (5)

Interventions

Exome (1)

Sponsors

University of California, San Francisco (2)  ·  Chinese University of Hong Kong (1)  ·  Hospices Civils de Lyon (1)  ·  Shanghai First Maternity and Infant Hospital (1)

Countries

United States (2)  ·  France (1)  ·  Hong Kong (1)

Top investigators

Mary Norton, MD (1)  ·  Teresa Sparks, MD (1)  ·  Teresa Sparks, MD, MAS (1)

Results publications

PMID 33027564

NIH funding

K12HD001262 (1), R01HD107190 (1)